Item 8.01. Other Events.

On June 21, 2012 Chelsea Therapeutics International, Ltd. issued a press release announcing results from an integrated dataset of two phase 3 studies for Northera(TM) (droxidopa) and information on seven additional droxidopa posters, all of which were presented at the Movement Disorder Society's Annual Congress held on June 18-21, 2012. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description

99.1 Press release dated June 21, 2012.